AcuCort AB Stock

Equities

ACUC

SE0009695927

Drug Retailers

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
0.56 SEK -6.67% Intraday chart for AcuCort AB +1.45% +34.94%
Sales 2021 3.46 37.88 Sales 2022 5.02 54.95 Capitalization 60.22M 659M
Net income 2021 -11M -120M Net income 2022 -14M -153M EV / Sales 2021 15,845,247 x
Net cash position 2021 35.85M 392M Net cash position 2022 17.18M 188M EV / Sales 2022 8,567,999 x
P/E ratio 2021
-5 x
P/E ratio 2022
-4.1 x
Employees 3
Yield 2021 *
-
Yield 2022
-
Free-Float 82.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day-6.67%
1 week+1.45%
Current month-6.67%
1 month+11.11%
3 months+63.74%
6 months+37.25%
Current year+34.94%
More quotes
1 week
0.48
Extreme 0.48
0.61
1 month
0.44
Extreme 0.44
0.70
Current year
0.34
Extreme 0.342
0.70
1 year
0.33
Extreme 0.327
1.60
3 years
0.33
Extreme 0.327
5.42
5 years
0.33
Extreme 0.327
7.90
10 years
0.33
Extreme 0.327
9.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-08
Members of the board TitleAgeSince
Director/Board Member 66 17-02-07
Director/Board Member 77 20-12-31
Director/Board Member 68 20-12-31
More insiders
Date Price Change Volume
24-04-25 0.56 -6.67% 1 644 357
24-04-25 0.6 +5.26% 1,561,091
24-04-24 0.57 +3.64% 1,149,640
24-04-23 0.55 +1.85% 1,184,193
24-04-22 0.54 0.00% 748,169

End-of-day quote NORDIC GROWTH MARKET, April 25, 2024

More quotes
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
More about the company